Evidence map›Paper›PMID 32863493›Full record

ArticleComputational statistics & data analysis2020

Structured Analysis of the High-dimensional FMR Model.

Mengque Liu, Qingzhao Zhang, Kuangnan Fang, Shuangge Ma

Abstract read
In one paragraph

Article in Computational statistics & data analysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mengque LiuSchool of Journalism and New Media, Xi'an Jiaotong University.
Qingzhao ZhangSchool of Economics, Xiamen University.
Kuangnan FangSchool of Economics, Xiamen University.
Shuangge MaSchool of Economics, Xiamen University.

Funding

Yale SPORE in Skin CancerP50CA121974 · NCI · YALE UNIVERSITY · PI RUTH HALABAN · 2006 to 2026
$43.9M
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung CancerP50CA196530 · NCI · YALE UNIVERSITY · PI Kurt A Schalper · 2015 to 2026
$31.1M
Integrated Cancer Modeling: A New DimensionR03CA241699 · NCI · YALE UNIVERSITY · PI MA, SHUANGGE · 2019 to 2020
$168k
NCI NIH HHS P50 CA121974NCI NIH HHS P50 CA196530NCI NIH HHS R03 CA241699
6 · The paper itself

Abstract

The finite mixture of regression (FMR) model is a popular tool for accommodating data heterogeneity. In the analysis of FMR models with high-dimensional covariates, it is necessary to conduct regularized estimation and identify important covariates rather than noises. In the literature, there has been a lack of attention paid to the differences among important covariates, which can lead to the underlying structure of covariate effects. Specifically, important covariates can be classified into two types: those that behave the same in different subpopulations and those that behave differently. It is of interest to conduct structured analysis to identify such structures, which will enable researchers to better understand covariates and their associations with outcomes. Specifically, the FMR model with high-dimensional covariates is considered. A structured penalization approach is developed for regularized estimation, selection of important variables, and, equally importantly, identification of the underlying covariate effect structure. The proposed approach can be effectively realized, and its statistical properties are rigorously established. Simulation demonstrates its superiority over alternatives. In the analysis of cancer gene expression data, interesting models/structures missed by the existing analysis are identified.

Indexed as

Finite mixture of regression modelHigh-dimensional dataStructure of covariate effect

Identifiers

PMID32863493
PMCPMC7451155

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.